Acta Chir Orthop Traumatol Cech. 2007; 74(4):247-252 | DOI: 10.55095/achot2007/038

Involvement of Immunogenetic Factors in the Development of Periprosthetic OsteolysisCurrent concepts review

J. GALLO1,*, F. MRÁZEK2, M. PETŘEK2
1 Ortopedická klinika, LF UP a FN Olomouc
2 Ústav imunologie, LF UP a FN Olomouc

Aseptic loosening and osteolysis are the most frequent causes of total hip or total knee arthroplasty failure. Osteolysis is induced predominantly by polyethylene particles that are produced by adhesive wear of the prosthesis. The particles trigger a complex host's reaction varying in intensity even in response to the same number of particles. These differences indicate that individual predisposition may have an important role in the pathogenesis of osteolysis. The major key mediators of wear-induced osteolysis include the cytokines RANKL, TNF-a, IL-1, IL-6 and IL-8. The inter-individual differences in the extent of bone destruction may therefore be related to variation in the amount and/or activity of these cytokines based on their gene polymorphism. Our pilot study suggests an association of some variants of the cytokine genes (e.g., IL1A-889) with a predisposition to development of severe osteolysis. If this assumption is confirmed by future investigations, this approach can facilitate the pre-operative identification of patients at risk of the development of severe periprosthetic osteolysis and premature failure of the implant.

Keywords: osteolysis, total joint replacement, failure, polyethylene disease, cytokines, gene polymorphism, genetic risk

Accepted: January 15, 2007; Published: August 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
GALLO J, MRÁZEK F, PETŘEK M. Involvement of Immunogenetic Factors in the Development of Periprosthetic Osteolysis. Acta Chir Orthop Traumatol Cech. 2007;74(4):247-252. doi: 10.55095/achot2007/038. PubMed PMID: 17877940.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. AMBRŮZOVÁ, Z., GALLO, J., MRÁZEK, F., KUBI©TOVÁ, Z., ONDERKOVÁ, J., PETŘEK, M.: Association of cytokine gene polymorphisms with the expansive periprosthetic osteolysis in total hip arthroplasty. Tissue Antigens, 67:528, 2006.
    2. BENNERMO, M., HELD, C., STEMME, S., ERICSSON, C.G., SILVEIRA, A., GREEN, F., TORNVALL, P.: Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin. Chem., 50:2136-2140, 2004. Go to original source... Go to PubMed...
    3. BOYCE, B.F., SCHWARZ, E.M., XING, L.: Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol., 18:427-432, 2006. Go to original source... Go to PubMed...
    4. CAMPBELL, P., SHEN, F.W., McKELLOP, H.: Biologic and tribologic considerations of alternative bearing surfaces. Clin. Orthop., 418:98-111, 2004. Go to original source... Go to PubMed...
    5. CAPELLO, W.N., DīANTONIO, J.A., FEINBERG, J.R., MANLEY, M.T.: Alternative bearing surfaces: alumina ceramic bearings for total hip arthroplasty. Instr. Course Lect. (AAOS), 54:171-176, 2005. Go to PubMed...
    6. ČECH, O., D®UPA, V.: The European school of total hip arthroplasty and 35 years of total hip arthroplasty in the Czech Republic. Acta Chir. orthop. Traum. čech., 72:57-76, 2005.
    7. DORR, L.D., LONG, W.T.: Metal-on-metal: articulations for the new millennium. Instr. Course Lect. (AAOS), 54:177-182, 2005. Go to PubMed...
    8. FARGION, S., VALENTI, L., DONGIOVANNI, P., FRACANZANI, A.L.: TNF alpha promoter polymorphisms. Methods Mol. Med., 98:47-58, 2004.
    9. FIORITO, S., MAGRINI, L.,, GOALARD, C.: Pro-inflammatory and anti-inflammatory circulating cytokines and periprosthetic osteolysis. J. Bone Jt Surg., 85-B:1202-1206, 2003. Go to original source... Go to PubMed...
    10. FITZGERALD, R.H., JR., KELLY, P.J.: Total joint arthroplasty. Biologic causes of failure. Mayo Clin. Proc., 54:590-596, 1979.
    11. GALLO, J., HAVRÁNEK, V., ČECHOVÁ, I., ZAPLETALOVÁ, J.: Influence of demographic, surgical and implant variables on wear rate and osteolysis in ABG I hip arthroplasty. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 150: 135-141, 2006. Go to original source... Go to PubMed...
    12. GALLO, J., KAMÍNEK, P., TICHÁ, V., ŘIHAKOVÁ, P., DITMAR, R.: Particle disease. A comprehensive theory of periprosthetic osteolysis: a review. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 146:21-28, 2002. Go to original source... Go to PubMed...
    13. GALLO, J., KAMÍNEK, P., ZAPLETALOVÁ, J., ČECHOVÁ, I., ©PIČKA, J., DITMAR, R.: Je osteolýza kolem stabilní TEP kyčelního kloubu asymptomatická? Acta Chir. orthop. Traum. čech., 71:20-25, 2004.
    14. GALLO, J., MRÁZEK, F., AMBRŮZOVÁ, Z., PETŘEK, M.: Individuální dispozice k selhání endoprotézy. X. národní kongres ČSOT, Praha, 17.-20.5. 2006; Kniha abstrakt, s. 42.
    15. GARRIGUES, G.E., CHO, D.R., RUBASH, H.E., GOLDRING, S.R., HERNDON, J.H., SHANBHAG, A.S.: Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. Biomaterials, 26: 2933-2945, 2005. Go to original source... Go to PubMed...
    16. HARRIS, W.H.: Conquest of a worldwide human disease: particle-induced periprosthetic osteolysis. Clin. Orthop., 429:39-42, 2004. Go to original source... Go to PubMed...
    17. HARRIS, W.H.: Osteolysis and particle disease in hip replacement. A review. Acta orthop. scand., 65:113-123, 1994. Go to original source... Go to PubMed...
    18. INGHAM, E., FISHER, J.: The role of macrophages in osteolysis of total joint replacement. Biomaterials, 26:1271-1286, 2005. Go to original source... Go to PubMed...
    19. JANÍČEK, P., JANÍČEK, P., FUIS, V., PINK, T.: Necementovaná totální endoprotéza kyčelního kloubu, keramika-keramika. Acta Chir. orthop. Traum. čech., 73:283-286, 2006. Go to original source...
    20. KORENY, T., TUNYOGI-CSAPO, M., GAL, I., VERMES, C., JACOBS, J.J., GLANT, T. T.: The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum., 54:3221-3232, 2006. Go to original source... Go to PubMed...
    21. KUBI©TOVÁ, Z., MRÁZEK, F., TÜDÖS, Z., KRIEGOVÁ, E., AMBRŮZOVÁ, Z., MYTILINEOS, J., PETŘEK, M.: Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int. J. Immunogenet., 33:261-267, 2006. Go to original source... Go to PubMed...
    22. LOONEY, R.J., SCHWARZ, E.M., BOYD, A., O'KEEFE, R.J.: Periprosthetic osteolysis: an immunologist's update. Curr. Opin. Rheumatol., 18:80-87, 2006. Go to original source... Go to PubMed...
    23. MA, G., AINOLA, M., LILJESTROM, M., SANTAVIRTA, S., PODUVAL, P., ZHAO, D., CHEN, T., KONTTINEN, Y.T.: Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants. J. Rheumatol., 32:1943-1950, 2005.
    24. MALIK, M.H., JURY, F., ZEGGINI, E., BAYAT, A., OLLIER, W.E., KAY, P.R.: Failed total hip replacement candidate gene analysis. Rheumatology (Oxford), 43 (Suppl.2): p.32, 2004. Go to PubMed...
    25. MALIK, M.H., BAYAT, A., JURY, F., OLLIER, W.E., KAY, P.R.: Genetic susceptibility to hip arthroplasty failure-association with the RANK/OPG pathway. Int. Orthop., 30:177-181, 2006. Go to original source... Go to PubMed...
    26. MALIK, M.H., JURY, F., SALWAY, F., PLATT, H., ZEGGINI, E., OLLIER, W.E.R., KAY, P.R.: Genetic susceptibility to deep infection and aseptic loosening of cemented total hip replacement. The role of the THF-alpha gene. 30th European Symposium on Calcified Tissues. Rome, Italy, May 8-12, 2003. Abstract book: p. 436.
    27. MANDELIN, J., LI, T.F., HUKKANEN, M., LILJESTROM, M., SALO, J., SANTAVIRTA, S., KONTTINEN, Y.T.: Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J. Rheumatol., 32:713-720, 2005. Go to PubMed...
    28. McKELLOP, H.A., CAMPBELL, P., PARK, S.H., SCHMALZRIED, T.P., GRIGORIS, P., AMSTUTZ, H.C., SARMIENTO, A.: The origin of submicron polyethylene wear debris in total hip arthroplasty. Clin. Orthop., 311:3-20, 1995.
    29. NAKASHIMA, Y., SUN, D.H., TRINDADE, M.C., CHUN, L.E., SONG, Y., GOODMAN, S.B., SCHURMAN, D.J., MALONEY, W.J., SMITH, R.L.: Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J. Bone Jt Surg., 81-B:155-162, 1999. Go to original source...
    30. POKORNÝ, D., ©LOUF, M., HORÁK, Z., JAHODA, D., ENTLICHER, G., EKLOVÁ, S., SOSNA, A.: Metodika sledování distribuce otěrových částic UHMWPE v okolních tkáních u TEP kyčelního kloubu. Acta Chir. orthop. Traum. čech., 73:243-250, 2006. Go to original source...
    31. SCHMALZRIED, T.P., SHEPHERD, E.F., DOREY, F.J., JACKSON, W.O., DELA ROSA, M., FA'VAE, F., McKELLOP, H.A., McCLUNG, C.D., MARTELL, J., MORELAND, J.R., AMSTUTZ, H.C.: The John Charnley Award. Wear is a function of use, not time. Clin. Orthop., 381:36-46, 2000. Go to original source... Go to PubMed...
    32. ©LOUF, M., ©LOUFOVÁ, I., HORÁK, Z., ©TĚPÁNEK, P., ENTLICHER, G., KREJČÍK, M., RADONSKÝ, T., POKORNÝ, D., SOSNA, A.: New fast method for determination of number of UHMWPE wear particles. J. Mater. Sci. Mater. Med., 15: 1267-1278, 2004. Go to original source... Go to PubMed...
    33. SOSNA, A., RADONSKÝ, T., POKORNÝ, D., VEIGL, D., HORÁK, Z., JAHODA, D.: Polyetylenová nemoc. Acta Chir. orthop. Traum. čech., 70: 6-16, 2003.
    34. STEINSSON, K., ALARCON-RIQUELME, M.E.: Genetic aspects of rheumatic diseases. Scand. J. Rheumatol., 34:167-177, 2005. Go to original source... Go to PubMed...
    35. STREICH, N.A., BREUSCH, S.J., SCHNEIDER, U.: Serum levels of interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and elastase in aseptic prosthetic loosening. Int. Orthop., 27:267-271, 2003. Go to original source... Go to PubMed...
    36. TANAKA, R., YASUNAGA, Y., HISATOME, T., YAMASAKI, T., IWAMORI, H., OCHI, M.: Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J. Arthroplasty, 20:1049-1054, 2005. Go to original source... Go to PubMed...
    37. WADDELL, J., PRITZKER, K.P., BOYNTON, E.L.: Increased cytokine secretion in patients with failed implants compared with patients with primary implants. Clin. Orthop., 434:170-176, 2005. Go to original source... Go to PubMed...
    38. WILKINSON, J.M., HAMER, A.J., STOCKLEY, I., EASTELL, R.: Polyethylene wear rate and osteolysis: critical threshold versus continuous dose-response relationship. J. Orthop. Res., 23:520-525, 2005. Go to original source... Go to PubMed...
    39. WILKINSON, J.M., WILSON, A.G., STOCKLEY, I., SCOTT, I.R., MACDONALD, D.A., HAMER, A.J., DUFF, G.W., EASTELL, R.: Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J. Bone Miner. Res., 18: 1995-2001, 2003. Go to original source... Go to PubMed...

    Return to the content